MOST NOTEWORTHY:

• St. Jude Medical's (NYSE: STJ) upgrade to Outperform from Market Perform at Wachovia was based on signs of an ICD recovery and reasonable valuation.

• Baird upgraded shares of Juniper (NASDAQ: JNPR) to Outperform from Neutral following better-than-expected guidance; Goldman upgraded Juniper to Buy from Neutral.

• Satyam (NYSE: SAY) was upgraded to Positive from Neutral at Susquehanna citing better than expected growth.

• Clearwire (NASDAQ: CLWR) was upgraded to Outperform from Peer Perform at Bear Stearns following the announcement that Sprint (S) and Clearwire will form a Nationwide 4G/Wimax Network.

• Citrix (NASDAQ: CTXS) was upgraded at Jefferies to Buy from Hold as they believe the strong customer response to Presentation Server Platinum Edition and the pipeline buildup related to NetScaler 8.0 bode well for the second half of 2007...

• Lehman raised DSW Inc (NYSE: DSW) to Overweight from Equal-Weight.

• Goldman upgraded shares of Labor Ready (NYSE: LRW) to Neutral from Sell.

• Rodman upgraded shares of Encysive Pharma (NASDAQ: ENCY) to Market Perform from Underperform.

• Lazard upgraded Cubist Pharmaceuticals (NASDAQ: CBST) to Neutral from Sell.

• Selective Insurance (NASDAQ: SIGI) was upgraded at Fox Pitt to In Line from Underperform.

• Raymond James upgraded Pfizer (NYSE: PFE) to Strong Buy from Market Perform.

Analyst upgrades 7-19-07: DSW, JNPR and PFE originally appeared on BloggingStocks on Thu, 19 Jul 2007 10:48:00 EST. Please see our terms for use of feeds.